Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole L Wallis

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2013
Laboratory challenges conducting international clinical research in resource-limited settingsJoseph E Fitzgibbon, Carole L Wallis
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2009
Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa?Wendy S Stevens, Carole L Wallis, Ian Sanne, et al.
Open Forum Infectious Diseases|October 6, 2016
Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230Saran Vardhanabhuti, David Katzenstein, John Bartlett, et al.
The Journal of Infectious Diseases|December 6, 2017
Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income CountriesCarole L Wallis, Catherine Godfrey, Joseph E Fitzgibbon, et al.
The Journal of Infectious Diseases|October 12, 2018
Reply to Suthar et alCarole L Wallis, Catherine Godfrey, Joseph E Fitzgibbon, et al.
The Pediatric Infectious Disease Journal|November 26, 2009
Emergence of drug resistance in HIV-1 subtype C infected children failing the South African national antiretroviral roll-out programCarole L Wallis, Linda Erasmus, Sheba Varughese, et al.
The Journal of Infectious Diseases|July 16, 2015
Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 InfectionAnne Derache, Carole L Wallis, Saran Vardhanabhuti, et al.
Virus Genes|October 5, 2010
Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patientCarole L Wallis, Willem D F Venter, Wendy S Stevens, et al.
Southern African Journal of HIV Medicine|August 25, 2020
Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapyKairoonisha Mahomed, Carole L Wallis, Liezl Dunn, et al.
AIDS Research and Treatment|April 15, 2011
Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South AfricaCarole L Wallis, John W Mellors, Willem D F Venter, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2013
Laboratory challenges conducting international clinical research in resource-limited settingsJoseph E Fitzgibbon, Carole L Wallis
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2009
Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa?Wendy S Stevens, Carole L Wallis, Ian Sanne, et al.
Open Forum Infectious Diseases|October 6, 2016
Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230Saran Vardhanabhuti, David Katzenstein, John Bartlett, et al.
The Journal of Infectious Diseases|December 6, 2017
Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income CountriesCarole L Wallis, Catherine Godfrey, Joseph E Fitzgibbon, et al.
The Journal of Infectious Diseases|October 12, 2018
Reply to Suthar et alCarole L Wallis, Catherine Godfrey, Joseph E Fitzgibbon, et al.
The Pediatric Infectious Disease Journal|November 26, 2009
Emergence of drug resistance in HIV-1 subtype C infected children failing the South African national antiretroviral roll-out programCarole L Wallis, Linda Erasmus, Sheba Varughese, et al.
The Journal of Infectious Diseases|July 16, 2015
Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 InfectionAnne Derache, Carole L Wallis, Saran Vardhanabhuti, et al.
Virus Genes|October 5, 2010
Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patientCarole L Wallis, Willem D F Venter, Wendy S Stevens, et al.
Southern African Journal of HIV Medicine|August 25, 2020
Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapyKairoonisha Mahomed, Carole L Wallis, Liezl Dunn, et al.
AIDS Research and Treatment|April 15, 2011
Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South AfricaCarole L Wallis, John W Mellors, Willem D F Venter, et al.
Pageof 9